- Medicare spending cuts are affecting diabetes device companies like Insulet and Dexcom.
- CMS proposed payment reductions impacting diabetes care.
Dexcom submitted positive CONNECT trial results to CMS.
1 report, 1 independent
Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Dexcom submitted positive CONNECT trial results to CMS.